Evidence map›Paper›PMID 36153664›Full record

ArticleProtein science : a publication of the Protein Society2022

Structure and specificity of an anti-chloramphenicol single domain antibody for detection of amphenicol residues.

Charles A Swofford, Sarah A Nordeen, Lu Chen, Mahaam M Desai, Joanna Chen, Stacy L Springs, Thomas U Schwartz, Anthony J Sinskey

Open access · hybridAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Assessing structural prediction accuracy for nanobody-small molecule complexes.Protein engineering, design & selection : PEDS · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Charles A SwoffordDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0001-5885-8286
Sarah A NordeenDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Lu ChenCenter for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Mahaam M DesaiCenter for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Joanna ChenCenter for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Stacy L SpringsCenter for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0003-2133-5689
Thomas U SchwartzDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0001-8012-1512
Anthony J SinskeyDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0002-1015-1270
Massachusetts Institute of Technology · US

Funding

User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI MALCOLM S. CAPEL · 2018 to 2026
$34.2M
NIGMS NIH HHS P30 GM124165
6 · The paper itself

Abstract

Antibiotics in aquaculture prevent bacterial infection of fish, but their misuse is a public health risk and contributes to the unintentional creation of multiresistant pathogens. Regulatory agencies cannot do the rigorous, expensive testing required to keep up with the volume of seafood shipments. Current rapid test kits for these drugs enable the increase in testing needed for adequate monitoring of food supply chains, but they lack a high degree of accuracy. To combat this, we set out to discover and engineer single-domain antibodies (VHHs) that bind to small molecule antibiotics, and that can be used in rapid test kits. The small size, solubility, and stability of VHHs are useful properties that can improve the reliability and shelf-life of test kits for these adulterants. Here, we report a novel anti-chloramphenicol VHH (Chl-VHH) with a disassociation constant of 57 nM. This was achieved by immunizing a llama against a chloramphenicol-keyhole limpet hemocyanin (KLH) conjugate and screening for high affinity binders through phage display. The crystal structure of the bound-VHH to chloramphenicol was key to identifying a mutation in the binding pocket that resulted in a 16-fold improvement in binding affinity. In addition, the structure provides new insights into VHH-hapten interactions that can guide future engineering of VHHs against additional targets.

Indexed as

Camelids, New WorldSingle-Domain AntibodiesAnimalsAnti-Bacterial AgentsAntibody SpecificityChloramphenicolReproducibility of ResultsAnti-Bacterial AgentsChloramphenicolSingle-Domain Antibodiesantibioticschloramphenicolfood adulterationhaptensnanobodiessingle-domain antibodiesVHH

Identifiers

PMID36153664
PMCPMC9601811
OpenAlexW4297199953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.